• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Lactobacillus plantarum CCFM8610 Alleviates Irritable Bowel Syndrome and Prevents Gut Microbiota Dysbiosis:A Randomized,Double-Blind,Placebo-Controlled,Pilot Clinical Trial

    2021-07-08 03:42:46YangLiuXinjieYuLeileiYuFengweiTianJianxinZaoHaoZangLongQianQunWangZengqingXueQixiaoZaiWeiCen
    Engineering 2021年3期

    Yang Liu,Xinjie Yu,Leilei Yu,Fengwei Tian,d,Jianxin Zao,Hao Zang,e,f,g,Long Qian,Qun Wang,Zengqing Xue,Qixiao Zai,d,*,Wei Cen,e,i

    a State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China

    b School of Food Science and Technology,Jiangnan University,Wuxi 214122,China

    c Hwa Chong Institution(College),Singapore 269734,Singapore

    d International Joint Research Laboratory for Probiotics,Jiangnan University,Wuxi 214122 China

    e National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China

    f Wuxi Translational Medicine Research Center and Jiangsu Translational Medicine Research Institute Wuxi Branch,Wuxi 214122,China

    g(Yangzhou)Institute of Food Biotechnology,Jiangnan University,Yangzhou 225004,China

    h The Tinghu People’s Hospital,Yancheng 224002,China

    i Beijing Advanced Innovation Center for Food Nutrition and Human Health,Beijing Technology and Business University(BTBU),Beijing 100048,China

    Keywords:

    ABSTRACT Irritable bowel syndrome with diarrhea(IBS-D)is chronic intestinal dysfunction with diarrhea and other complicated clinical symptoms,and it has a great impact on the daily life and mental state of patients.Some studies have reported that ingestion of probiotics can significantly alleviate a variety of intestinal diseases.The purpose of this study was to investigate the IBS-D-alleviating effects of a probiotic strain,Lactobacillus plantarum(L.plantarum)CCFM8610,with multiple health-promoting effects.The study was a 12-week,randomized,double-blind,placebo-controlled,pilot clinical trial.Seventy-five patients were randomly assigned to receive the placebo,oligosaccharides,or L.plantarum CCFM8610(1×1010 colony-forming units(CFU)per day),with a 2-week run-in period,an 8-week intervention period,and a 2-week follow-up observation period.The patients’clinical symptoms and quality of life were examined by the IBS symptom severity scale(IBS-SSS)and the IBS quality of life scale(IBS-QOL).Changes in gut microbiota composition and diversity were measured at the end of the intervention period.The oral administration of L.plantarum CCFM8610 significantly decreased the IBS-SSS and IBS-QOL scores,reduced IBS-D symptom severity,recovered gut microbiota diversity,decreased the relative abundance of bloating-related genus Methanobrevibacter,and increased the relative abundance of butyric acidproducing genera,including Anaerostipes,Anaerotruncus,Bifidobacterium,Butyricimonas,and Odoribacter.These findings suggest that ingestion of L.plantarum CCFM8610 can significantly alleviate clinical symptoms and gut microbiota dysbiosis in IBS-D patients.The IBS-D-alleviating effect of L.plantarum CCFM8610 may be related to the increase in the relative abundance of butyric acid-producing genera in the intestine.

    1.Introduction

    Irritable bowel syndrome(IBS)is a chronic intestinal disease that is usually accompanied by intestinal dysfunction but does not cause organic lesions[1].The global prevalence of IBS currently exceeds 10%of the population[2].Due to this high prevalence and the lack of a cure,IBS has placed an enormous burden on the healthcare system in various countries.Based on the characteristics of a patient’s stool(hard lumps,loose,or watery stools),IBS can be divided into four subtypes,IBS with diarrhea(IBS-D),IBS with constipation,mixed IBS,and untyped IBS[3].IBS-D is a subtype of IBS,whose main symptoms include severe diarrhea,recurrent abdominal pain and bloating,and changes in defecation habits[4].Because the clinical symptoms of IBS-D are more urgent than those of other IBS subtypes,IBS-D patients are more restricted in their diets and daily activities[5].Moreover,among patients with various IBS subtypes,those with IBS-D must usually undergo more than ten times the number of examinations to determine the diagnosis,so the diagnosis cost is usually expensive[6].With the development of society,environmental pollution and mental pressure are also increasing[7,8].This social situation further leads to the popularity of IBS-D.Based on these circumstances,IBS-D patients experience more significant mental and economic stress.It is therefore essential to find an effective treatment for IBS-D as soon as possible.

    Multiple studies have indicated that many physiological characteristics of IBS-D patients undergo significant changes.The protein expression levels of cyclooxygenase-2 and prostaglandin E2were significantly higher in the colons of IBS-D patients than in those of healthy control subjects,which can lead to visceral hypersensitivity symptoms and aggravated functional intestinal disorders[9].The activation of mast cells in IBS-D patients results in a large amount of tryptase and histamine release,which exacerbates the degradation of occludin and increases intestinal permeability[10].Moreover,IBS-D patients also show severe gut microbiota disorders.There was a significant increase in the abundance of the bacterial phyla Firmicutes and Proteobacteria and a decrease in the abundance of Bacteroidetes in the microbiota of IBS-D patients[11].At the genus level,the abundance of several genera,like Bifidobacterium,Faecalibacterium,and Ruminococcus,also showed significant changes[12].

    Probiotics are living microorganisms that colonize and play a beneficial role in the human body and are often used to alleviate various diseases because of their general recognition as being safe to consume[13].Multiple animal models have proven that probiotics can alleviate gut microbiota dysbiosis,regulate the immune response,enhance intestinal barrier function,and inhibit visceral hypersensitivity[14–17].In several clinical trials,some probiotics have been shown to be effective in alleviating IBS.Clostridium butyricum was reported could decrease the defecation frequency of IBS patients and improve their fatty acid metabolism[18].The intervention of Bifidobacterium bifidum for eight weeks could significantly alleviate the abdominal pain and reduce the severity of IBS[19].Supplementation of Bifidobacterium longum significantly reduces depression of IBS patients and improve their quality of life[20].After four weeks of ingestion of Lactobacillus acidophilus,the bloating symptom of IBS patients decreased significantly,accompanied by a normalization of bowel habits[21].These pieces of evidence indicate that probiotics are now receiving attention as a potential treatment for IBS.

    Lactobacillus plantarum(L.plantarum)CCFM8610 is a probiotic strain previously isolated from fermented vegetables with superior physiological characteristics.In vitro experiments indicated that L.plantarum CCFM8610 has a survival rate of 83.18%±0.34% after being treated with the simulated gastrointestinal environment,an oligosaccharide fermentability with inulin,fructooligosaccharides,and galactooligosaccharides, a generation time of(124.2±4.33)min,and a conjugated linoleic acid conversion rate of 57.39%±1.08%[22].Compared with other Lactobacillus strains,L.plantarum CCFM8610 has significant advantages in these physiological characteristics.These excellent physiological characteristics are helpful for the strain to play a health-promoting role in vivo.In animal experiments,L.plantarum CCFM8610 has been demonstrated to significantly increase the expression of zonula occludens(ZO)-1,occludin,and claudin-1,thereby restoring intestinal barrier function[23].In a colitis model,L.plantarum CCFM8610 reduced the expression of pro-inflammatory cytokines such as interleukin(IL)-6 and tumor necrosis factor(TNF)-αin the colon and inhibited the activation of the nuclear factor(NF)-κB-signaling pathway to relieve intestinal inflammation[22].Clinical trials have also indicated that supplementation with L.plantarum CCFM8610 significantly restores gut microbiota diversity and improves gut microbiota composition[24].Therefore,we believe that this strain has the potential to alleviate the clinical symptoms of IBS-D patients.To test this hypothesis,we designed a randomized,double-blind,placebo-controlled,pilot clinical study to investigate the efficacy of L.plantarum CCFM8610 in alleviating IBS-D.The study design and results provide new evidence for probiotics as a treatment to alleviate IBS-D symptoms and lay a foundation to explore the mechanism of probiotic treatment to alleviate IBS more broadly.

    2.Materials and methods

    2.1.Study design and ethics statement

    The study was a 12-week,randomized,double-blind,placebocontrolled,pilot clinical study conducted in the Tinghu People’s Hospital of Yancheng,Jiangsu,China.The study design and ethics statement were approved by the Ethics Committee of Tinghu People’s Hospital of Yancheng(Ethical No.ET2017015)and registered at Chinese Clinical Trial Registry(ChiCTR)??http://www.chictr.org.cn/index.aspx(Registration No.:ChiCTR1800014886).The study was conducted in accordance with the Helsinki Declaration,and informed consent was obtained from each participant.

    2.2.Study population

    Patient recruitment for this study was conducted in February and March 2018.According to the research of Niv et al.[25],we have formulated the inclusion and exclusion criteria for this study.Patients at least 18 years of age with a diagnosis of IBS-D were recruited in this study.Two digestive physicians evaluated patients for IBS-D symptoms based on the Rome III criteria.Moreover,the patient needs to agree to provide an informed consent form.However,the following groups were excluded:patients with infectious diseases or gastrointestinal cancer;patients with preexisting inflammatory bowel disease or other intestinal diseases;patients who had taken anti-diarrheal drugs or antibiotics within the past month;patients who had taken microecologics,dietary supplements or probiotics within the past month;patients who regularly drank yogurt or probiotic beverages;patients with significant recent changes in their eating habits;and women who were or hoped to become pregnant.During the study,any patient who failed to take the probiotics on time,failed to retain their fecal samples,or failed to complete the questionnaire were considered to be automatically withdrawn.

    2.3.Study products

    The products used in this study included placebo products,oligosaccharide products,and L.plantarum CCFM8610 products.All products were in the form of powder and had the same appearance and the same packaging(2 g?pack-1).The ingredient of the placebo product was maltodextrin.Oligosaccharides product consisted of 5% maltodextrin and oligosaccharides(7.8% inulin,15.6%galactooligosaccharides,and 71.6%fructooligosaccharides).L.plantarum CCFM8610 product contained L.plantarum CCFM8610(5%,>5×109colony-forming units(CFU)per gram)and oligosaccharides with an identical amount to oligosaccharides product.All products need to be stored at 4 °C.The viable bacterial amount of L.plantarum CCFM8610 in the product remains over 5×109CFU?g-1within three months.

    2.4.Randomization and intervention

    Initially,a total of 96 patients were recruited in this study.After a physical examination,21 patients were excluded because they did not meet the study requirements.According to the computer-generated random number table,the remaining 75 patients were divided into three groups(placebo group,oligosaccharides group,and L.plantarum CCFM8610 group),with 25 patients in each group.

    The total length of the study was 12 weeks,with a run-in period of two weeks(weeks 1 and 2),an intervention period of eight weeks(weeks 3–10),and a 2-week follow-up observation period(weeks 11 and 12).The purpose of the run-in period was to allow patients to check their IBS-D symptoms.Each group of patients was required to take the corresponding product(2 g)daily during the intervention period.During the follow-up observation period,the patients stopped taking the probiotics but were asked to report any adverse health conditions.

    Moreover,throughout the study,the patients were required to refrain from taking antibiotics;any drugs related to gastrointestinal problems;or other probiotics,probiotic drinks,yogurts,microecological agents,or dietary supplements.The patients were also asked not to make significant changes in their eating habits and not to participate in other clinical trials.

    2.5.Questionnaire survey

    According to the research of Niv et al.[25],the IBS symptom severity scale(IBS-SSS)and IBS quality of life scale(IBS-QOL)were used in this study to investigate the clinical symptoms and quality of life of IBS-D patients.With the help of a physician,patients reported their IBS-SSS score and IBS-QOL score in weeks 3,7,and 11.

    2.6.Feces sample collection and fecal microbiota analysis

    One feces sample collection was arranged in this study at week 11.Fresh fecal samples were collected and stored at-80 °C.Fecal DNA was extracted according to the instructions of the FastDNA?Spin kit(MP Biomedicals Ltd.,USA).Polymerase chain reaction(PCR)and sequencing of gut microbiota were performed according to the method described by Wang et al.[26].Principal component analysis(PCA)and linear discriminant analysis effect size(LEfSe)analysis were used to analyze the species in the gut microbiota.

    2.7.Statistical analysis

    The measurement data that fit the normal distribution in this study were expressed as mean±standard deviation(SD).Oneway analysis of variance(ANOVA)was used to analyze the results,followed by Tukey’s multiple comparison test to determine statistical significance.

    The measurement data in this study that did not meet the normal distribution were expressed as medians(interquartile range).A nonparametric test was used to analyze the results.The Friedman rank-sum test was used to determine the statistical significance of the IBS-SSS and IBS-QOL questionnaire data due to the pairing properties of their samples.The Kruskal–Wallis ANOVA was used to determine the statistical significance of the gut microbiota data due to the independent properties of their samples.

    The enumeration data were directly expressed as a number.A chi-square test was used to determine the statistical significance of the primary data of patients,and the Mann–Whitney U test was used to determine the statistical significance of the severity of IBS in different groups.p-values less than 0.05 were considered to be statistically significant.

    3.Results

    3.1.Patients and baseline characteristics

    Sixty-three patients completed the study.Twelve patients were lost to follow-up and were excluded from the study(Fig.1).The primary data of patients in each group are shown in Table 1.No significant differences were seen in the baseline characteristics of each group.

    3.2.Effects of L.plantarum CCFM8610 on IBS-D clinical symptoms and IBS-D severity

    The IBS-SSS questionnaire scores changed significantly after the 8-week intervention period(Table 2).Patients who took the placebo reported a significant improvement in their bowel habit satisfaction(p<0.05),but this improvement occurred only in the first four weeks of the intervention period,and no improvement was seen in the last four weeks.Moreover,during the 8-week intervention period,no significant change was seen in the total IBS-SSS scores of this group(p>0.05).The patients in the L.plantarum CCFM8610 group indicated improvements in their bloating symptoms,bowel habit satisfaction,and life interference scores after supplementation with L.plantarum CCFM8610 and continued to improve over eight weeks(p<0.05).After eight weeks of treatment,the total IBS-SSS scores of L.plantarum CCFM8610 group patients decreased significantly(p<0.05).The patients in the oligosaccharides group did not show any significant improvement in IBS symptoms(p>0.05).

    The number of patients with severe IBS symptoms in the placebo group increased after eight weeks of intervention(Table 2).No significant difference was seen in the number of patients with different symptoms between week 3 and week 11(p>0.05).Similarly,no significant changes in the number of patients with different symptoms were observed in the oligosaccharides group(p>0.05).However,after eight weeks of treatment,many patients with moderate symptoms who ingested L.plantarum CCFM8610 reported only mild symptoms.Furthermore,all patients with severe symptoms in the L.plantarum CCFM8610 group saw improvement to moderate symptoms.This indicates L.plantarum CCFM8610 effectively alleviated overall IBS symptoms(p<0.05).

    3.3.Effects of L.plantarum CCFM8610 on quality of life of IBS-D patients

    The results of the IBS-QOL survey show that the effects of the different products were quite distinct(Table 2).The patients in the placebo group did not report any significant changes in their total IBS-QOL scores.However,they reported fewer concerns about their health after taking the placebo(p<0.05).The same conclusions were also reported by the oligosaccharides group(p<0.05),and the patients in the oligosaccharides group also reported a significant reduction in their concerns about interpersonal relationships(p<0.05).However,the total IBS-QOL score for this group of patients,including the emotion score,activity interference score,and food avoidance score,showed a significant increase in week 7(p<0.05).Similar results also appeared in some sub-scoring items of the placebo group(such as emotion,body image,and interpersonal relationships),but the changes were not statistically significant.The scores returned to baseline by week 11.This indicates that IBS-D symptoms significantly affected quality of life during the intervention period.Compared with placebo and oligosaccharides,L.plantarum CCFM8610 significantly reduced the impact of IBS on the patients’quality of life.The patients in the L.plantarum CCFM8610 group reported significant improvements in emotion control,diet control,social reaction,and overall quality of life(p<0.05).

    Fig.1.Flowchart of patients.

    Table 1 Baseline characteristics of patients in each group.

    3.4.Effects of L.plantarum CCFM8610 on gut microbiota diversity and composition of IBS-D patients

    The Simpson index and Shannon index of patients in the L.plantarum CCFM8610 group were significantly higher than those in the placebo group(Figs.2(a)and(b)).This indicates that the intervention of L.plantarum CCFM8610 increased the diversity of gut microbiota.Treatment with oligosaccharides had no significant effect.

    The relative abundance of the gut microbiota at the genus level in each group differed significantly(Fig.2(c)).The relative abundance of the genus Prevotella in the placebo group was the highest of all genera in all groups.However,treatment with probiotics or oligosaccharides significantly altered the gut microbiota composition.Compared with other groups,the oligosaccharides group experienced a significant increase in the relative abundance of several genera.The oral administration of L.plantarum CCFM8610 resulted in a higher relative abundance of Bifidobacterium.

    The results of PCA demonstrate that supplementation with oligosaccharides or probiotics could change the composition of the gut microbiota(Fig.3(a)).However,after eight weeks of intervention,the changes in gut microbiota varied among groups.Compared to the placebo group,the ingestion of probiotics and oligosaccharides significantly increased the relative abundance of the genera Bacteroides and decreased the relative abundance of Prevotella(Figs.3(b)–(d)).In the L.plantarum CCFM8610 group,a significant increase was seen in the abundance of several genera,such as Ruminococcus and Parabacteroides.We also found that the relative abundance of a number of butyric acid-producing species changed significantly in the L.plantarum CCFM8610 group(Fig.3(c)).

    Table 2 IBS-SSS questionnaire scores and IBS-QOL questionnaire scores at weeks 3,7,and 11.

    Fig.2.Gut microbiota alpha diversity and main bacterial genera relative abundance in different groups.(a)Simpson index;(b)Shannon index;(c)heat map of genera percentage in bacteria with relative abundances>0.001.All data were analyzed by one-way ANOVA and Tukey’s multiple comparison test.Letters a and b indicate statistically significant differences(p<0.05).

    Fig.3.Principal component analysis and LEfSe analysis of gut microbiota composition in different groups.(a)Principal component(PC)analysis of gut microbiota;(b)least discriminant analysis(LDA)scores at the genus level of the placebo group and oligosaccharides group;(c)LDA scores at the genus level of the placebo group and L.plantarum CCFM8610 group;(d)taxonomic cladogram.

    3.5.Effects of L.plantarum CCFM8610 on the relative abundance of butyric acid-producing genera and bloating-related genus in IBS-D patients

    The bacterial genera Anaerostipes,Anaerotruncus,Bifidobacterium,Butyricimonas,and Odoribacter have notable butyric acidproducing abilities and also significantly changed in relative abundance after the intervention(Figs.4(a)–(e)).Compared with the placebo group,only the L.plantarum CCFM8610 group significantly increased the relative abundance of Anaerostipes,Anaerotruncus,Bifidobacterium,Butyricimonas,and Odoribacter(p<0.05).The relative abundance of Methanobrevibacter is related to the production of gas in the intestinal tract.The oral administration of L.plantarum CCFM8610 could significantly reduce the relative abundance of Methanobrevibacter(Fig.4(f);p<0.05).Treatment with oligosaccharides could regulate the relative abundance of some genera,but no significant difference was seen with the placebo treatment.

    Fig.4.Relative abundance of butyric acid-producing genera and bloating-related genus.(a)Anaerostipes;(b)Anaerotruncus;(c)Bifidobacterium;(d)Butyricimonas;(e)Odoribacter;(f)Methanobrevibacter.All data were analyzed by the Kruskal–Wallis ANOVA test and expressed as median±interquartile range.Letters a,b,and c indicate statistically significant differences(p<0.05).

    4.Discussion

    This study aimed to investigate the IBS-D symptom-alleviating effects of the bacterial strain L.plantarum CCFM8610,a probiotic strain with multiple health-promoting functions that we screened in a previous study.We designed a randomized,double-blind,placebo-controlled pilot clinical trial and analyzed the ability of L.plantarum CCFM8610 to alleviate the clinical symptoms of IBS-D,improve the quality of life of patients,and alleviate gut microbiota dysbiosis.

    In this study,patients were divided into three groups and were given three kinds of study products.In the L.plantarum CCFM8610 product,oligosaccharides were added as an adjuvant,because the oligosaccharides were reported could regulate immune response and promote the proliferation of beneficial microbiome in the intestine[27,28].However,whether oligosaccharides could alleviate IBS-D has always been controversial[29,30].Therefore,we set up a separate group to investigate the effects of oligosaccharides on alleviating IBS-D.The results show that oligosaccharides had no IBS-D-alleviating effects.This indicates that the alleviating effect of L.plantarum CCFM8610 products on IBS-D comes from the probiotic strain L.plantarum CCFM8610 alone.

    IBS-D is a subtype of IBS,and its severity is greatly affected by the patient’s physiological status,psychological state,dietary habits,and other environmental factors[4].Compared with other subtypes of IBS,IBS-D usually causes frequent abdominal pain and bloating,bad bowel habits,severe activity impairment,harsh food avoidance,and high treatment costs[31].Also,patients’economic productivity is greatly impaired by the clinical symptoms of IBS-D[32].Due to these factors,the quality of life of IBS-D patients is frequently low[5].To explore the alleviating effects of L.plantarum CCFM8610 on the quality of life of IBS-D patients,we set up two questionnaire surveys during the study to examine the patients’feelings.

    The IBS-SSS is a questionnaire commonly used in clinical studies to determine the severity of IBS.We found that,of the three intervention strategies in this study,only L.plantarum CCFM8610 reduced the patients’total IBS-SSS scores(Table 2).These results show that this strain can alleviate the clinical symptoms of IBS-D.Further analysis of the sub-scoring items of the IBS-SSS shows that L.plantarum CCFM8610 significantly alleviated the bloating symptoms and improved bowel habit satisfaction.Bloating is one of the main clinical symptoms of IBS-D and is usually associated with visceral hypersensitivity[33].For IBS-D patients,visceral hypersensitivity is characterized by an enhanced sense of pain in the intestinal tract,which is essentially a disorder of the peripheral and central nervous systems[34].This nervous system disorder reduces the threshold of gastrointestinal irritation,so IBS-D patients often suffer from abdominal pain and bloating[33].In animal models,Lactobacillus species have been proven to inhibit visceral hypersensitivity by increasing the pain threshold,reducing the contractile response of colonic smooth muscle,inhibiting the concentrations of serum corticosterone and spinal neurotransmitters,and regulating the hypothalamus–pituitary–adrenal axis[35,36].Our results are similar to these conclusions.Therefore,we speculated that the strain L.plantarum CCFM8610 might have similar effects and thereby alleviate the clinical symptoms of IBS-D in humans.

    Except for visceral hypersensitivity,IBS-D patients also have typical symptoms of lactose and fructose malabsorption,which prevents the full absorption of dietary carbohydrates in the small intestine.These unabsorbed carbohydrates are fermented by colonic microorganisms to produce a large amount of gas,resulting in severe bloating symptoms[37].L.plantarum usually plays a probiotic role in the colon.Due to the excellent adhesion and sugar fermentation abilities of L.plantarum,the unfermented sugars in the diet can be thoroughly absorbed in the colon to reduce gas production[38,39].Therefore,we propose that in addition to inhibiting visceral hypersensitivity,L.plantarum CCFM8610 may also inhibit bloating symptoms by reducing gas production in the colon.

    We found that both L.plantarum CCFM8610 and a placebo treatment could improve patients’bowel habit satisfaction.However,the effect of the placebo appeared only in the first four weeks of the intervention period,whereas the effect of L.plantarum CCFM8610 was consistent throughout the intervention period.In a previous study,L.plantarum CCFM8610 was shown to improve intestinal peristalsis[40],but no placebo(such as maltodextrin)has been reported to exert similar effects.Therefore,it is reasonable to speculate that the improvement of bowel habit satisfaction in the placebo group patients may be due to the placebo effect[41].L.plantarum CCFM8610 also significantly reduced the number of patients with severe and moderate IBS-D symptoms,but no significant change was seen in the number of patients with various symptoms in the placebo group(Table 2).

    We used the IBS-QOL to quantitatively evaluate the patients’quality of life.After analyzing the results of the IBS-QOL,we found that treatment with L.plantarum CCFM8610 significantly improved the total IBS-QOL score,alleviated concerns about diet and social impression,and improved emotional fluctuations(Table 2).Some foods can cause abdominal pain and abdominal distension,so IBS-D patients often have many restrictions on their diet[4].Also,the clinical symptoms of IBS-D often lead patients to avoid social activities and group travel,and these patients are usually worried about their social impressions[32,42].The inconveniences in diet and social activities directly cause significant emotional changes in IBS-D patients.The gut and the brain can communicate in both directions via the gut–brain axis[43].Intestinal stimulation and discomfort can lead to emotional changes in patients,and these emotional changes can cause intestinal visceral hypersensitivity symptoms and intestinal stress reactions via the vagus nerve[44].Emotional changes such as depression,anxiety,and compulsion in patients may also aggravate the symptoms of IBS-D and reduce quality of life[44,45].A meta-analysis of clinical trials of anxiety and depression by Liu et al.[46]found that Lactobacillus has the effect of alleviating anxiety and depression,whereas placebos and oligosaccharides do not.This result suggested that L.plantarum CCFM8610 might regulate the emotions of IBS-D patients.Moreover,due to the excellent carbohydrate utilization character of L.plantarum CCFM8610,the bloating symptoms were alleviated,and concerns about the patients’diet were improved.Hence,we believe that L.plantarum CCFM8610 can alleviate concerns about diet and improve emotional fluctuations,thus improving the quality of life of IBS-D patients.

    Gut microbiota dysbiosis is an important feature of IBS-D[47].Compared with healthy people,significant changes are seen in the composition of gut microbiota in IBS-D patients,and the diversity of gut microbiota is decreased[48].Many studies suggest that gut microbiota dysbiosis might be one of the causes of IBS-D[49].To explore the effects of probiotics on the gut microbiota of IBS-D patients,we sequenced the fecal microbiota and analyzed the diversity and differences in species between each group at the genus level.The results show that the intake of L.plantarum CCFM8610 significantly increased gut microbiota diversity and serve as preliminary evidence that probiotics alleviate gut microbiota dysbiosis(Fig.2).After further analysis of the various genera between each group,we found that in the placebo group Bacteroides were at a low relative abundance,whereas Prevotella had a high relative abundance.The intervention of oligosaccharides or probiotics can increase the relative abundance of Bacteroides and reduce the relative abundance of Prevotella.This change of relative abundances moves the composition of gut microbiota of IBS-D patients closer to that of healthy people[50,51].

    Moreover,except for Bacteroides and Prevotella,we found significant differences among the groups in the relative abundance of Methanobrevibacter,which is a type of anaerobic bacteria that can use hydrogen to reduce carbon dioxide to methane.Due to its gas-producing character,the increase in the relative abundance of Methanobrevibacter often causes severe gastrointestinal flatulence and exacerbates the clinical symptoms of IBS-D[52,53].In this study,L.plantarum CCFM8610 could reduce the relative abundance of Methanobrevibacter,which is consistent with previous results in which L.plantarum CCFM8610 significantly alleviated bloating symptoms in IBS-D patients.We conclude that L.plantarum CCFM8610 alleviates the IBS-D clinical symptoms by partially alleviating the dysbiosis of gut microbiota.

    Compared with other reported probiotics with IBS-D-alleviating effects,we found that L.plantarum CCFM8610 significantly increased the relative abundance of butyric acid-producing bacteria.At the genus level,a series of butyric acid-producing species,such as Anaerostipes,Anaerotruncus,Bifidobacterium,Butyricimonas,and Odoribacter,showed a high relative abundance level in the L.plantarum CCFM8610 group patients.Butyric acid is a short-chain fatty acid with many health-promoting effects.In the gut,butyric acid can reduce the expression of NF-κB,inhibit TNF-αrelease by macrophages,and activate the transcription factor hypoxiainducible factor(HIF)-1 in intestinal epithelial cells,thus maintaining the integrity of the intestinal barrier,reducing the inflammatory response of the intestine,and alleviating acute neuropathic pain and bloating[54–56].Butyrate is also an important histone deacetylase inhibitor that can promote histone acetylation in the host organism,thereby affecting brain function and possibly inhibiting depression[57,58].The relative abundance of butyric acid-producing genera in the gut of IBS-D patients was significantly lower than in healthy people[59].Therefore,the increase in butyric acid concentrations in the gut may achieve the dual regulation of IBS-D clinical symptoms and emotions.The fermentation of undigested carbohydrates in the gut by gut microbiota is the primary source of butyric acid[60].Therefore,one possible mechanism could be that the oral administration of L.plantarum CCFM8610 significantly increases the relative abundance of butyric acid-producing genera,which then promote the production of butyric acid in the intestine,thereby alleviating the clinical symptoms and negative emotions of IBS-D patients.This indicates that the alleviating effects of L.plantarum CCFM8610 on IBS-D clinical symptoms and quality of life are related to the increase of the relative abundance of butyric acid-producing genera.Meanwhile,some studies have demonstrated that the low gut microbiota diversity of IBS-D patients is related to the low relative abundance of butyric acid-producing genera[59].Therefore,the enhancement of the relative abundance of butyric acid-producing genera by L.plantarum CCFM8610 should be one of the mechanisms for the recovery of gut microbiota dysbiosis in IBS-D patients.Similar results have not been reported in previous studies of probiotics that alleviate IBS-D.This indicates that increasing the relative abundance of butyric acid-producing bacterial genera may be a strain-specific effect that is unique to L.plantarum CCFM8610.We believe that this is an advantage of the L.plantarum CCFM8610 strain in alleviating IBS-D.

    In addition to the above conclusions,L.plantarum CCFM8610 also has significant advantages in safety over other treatments for IBS-D.Treatment options for IBS are increasing daily but are accompanied by more complicated side effects.A lowfermentable,oligosaccharides,disaccharides,monosaccharides,and polyols(FODMAP)diet is only useful for some patients and can cause a massive change in the colon microbiota[61].Chemical drugs such as alosetron and eluxadoline relieve diarrhea but also can cause severe ischemic colitis,constipation,pancreatitis,and sphincter spasms[62,63].Some studies support the use of psychotherapy to alleviate IBS,but its efficacy has yet to be explored[4].These results indicate that most treatments for IBS-D still have severe defects.There also have been reports of adverse health conditions caused by probiotics.This indicates that the probiotics are not an entirely safe dietary ingredient.So,we have investigated the previous literature on adverse health events caused by probiotics.We found that most of the reports of probiotic adverse health events occurred in specific populations,such as intensive care unit patients[64],the elderly with immunodeficiency and malnutrition[65],or structural heart disease patients[66].For mild patients,probiotics hardly cause any adverse health events.The disease model of this study,IBS-D,does not cause any organic lesions.It is a relatively mild disease.Therefore,the possibility of adverse events is low.Furthermore,most of the adverse health events of probiotics are caused by Saccharomyces.There are very few adverse health events caused by Lactobacillus[67].Among the reports of

    Lactobacillus adverse events,Lactobacillus rhamnosus adverse events are the most common,which may be related to fimbriae structure and extracellular polysaccharide composition[68].Currently,there have been no reports of adverse events caused by L.plantarum.Moreover,before this study was conducted,our strain L.plantarum CCFM8610 had conducted several animal experiments[22,23,69]and one clinical study[24],and no adverse health events have occurred.Therefore,combined with the conclusion that no adverse events occurred in this study,we preliminarily concluded that the intervention of IBS-D with L.plantarum CCFM8610 is a healthy strategy.

    5.Conclusions

    The purpose of this study was to investigate the clinical effects of L.plantarum CCFM8610 on alleviating IBS-D symptoms.For this purpose,we designed a randomized,double-blind,placebocontrolled pilot clinical trial.The results show that L.plantarum CCFM8610 significantly restores the gut microbiota composition and diversity and alleviates clinical symptoms and negative emotions in IBS-D patients.We also found that the beneficial effects of L.plantarum CCFM8610 on gut microbiota,IBS-D clinical symptoms,and quality of life may be related to the increase in the relative abundance of butyric acid-producing bacterial genera.Our results verify the IBS-D-alleviating effect of probiotics and lay a foundation for the exploration of the mechanisms of alleviating IBS-D symptoms.

    Acknowledgements

    This work was supported by the National Natural Science Foundation of China Program(31871773 and 31820103010);National Key Research and Development Project(2018YFC1604206);Projects of Innovation and Development Pillar Program for Key Industries in Southern Xinjiang of Xinjiang Production and Construction Corps(2018DB002);National First-Class Discipline Program of Food Science and Technology(JUFSTR20180102);the Biotechnology and Biological Sciences Research Council(BBSRC)Newton Fund Joint Centre Award;and Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province.

    Compliance with ethics guidelines

    Yang Liu,Xinjie Yu,Leilei Yu,Fengwei Tian,Jianxin Zhao,Hao Zhang,Long Qian,Qun Wang,Zhengqing Xue,Qixiao Zhai,and Wei Chen declare that they have no conflict of interest or financial conflicts to disclose.

    深夜a级毛片| 色视频www国产| 国产精品伦人一区二区| 午夜免费男女啪啪视频观看| 亚洲欧美精品自产自拍| 国产精品人妻久久久影院| 国产免费视频播放在线视频 | 女人久久www免费人成看片| 男女边摸边吃奶| 九九久久精品国产亚洲av麻豆| 听说在线观看完整版免费高清| 国产成人aa在线观看| 一级爰片在线观看| 欧美日韩一区二区视频在线观看视频在线 | 大陆偷拍与自拍| 免费播放大片免费观看视频在线观看| 男女视频在线观看网站免费| av线在线观看网站| 九九在线视频观看精品| av又黄又爽大尺度在线免费看| 一区二区三区免费毛片| 国产大屁股一区二区在线视频| 欧美不卡视频在线免费观看| 亚洲国产av新网站| 国语对白做爰xxxⅹ性视频网站| 中文字幕免费在线视频6| 一个人看视频在线观看www免费| 国产极品天堂在线| 欧美日韩视频高清一区二区三区二| 人妻少妇偷人精品九色| 可以在线观看毛片的网站| 亚洲成人av在线免费| 亚洲av成人精品一二三区| 欧美日韩视频高清一区二区三区二| 国产乱来视频区| 小蜜桃在线观看免费完整版高清| 神马国产精品三级电影在线观看| 听说在线观看完整版免费高清| 精品一区二区免费观看| 免费观看性生交大片5| 麻豆精品久久久久久蜜桃| 精品久久久久久久人妻蜜臀av| 中文天堂在线官网| 我要看日韩黄色一级片| 男人和女人高潮做爰伦理| 亚洲成人久久爱视频| 免费看不卡的av| 国产精品伦人一区二区| 中文字幕制服av| 精品久久久久久久人妻蜜臀av| 欧美三级亚洲精品| 日本wwww免费看| 亚洲av一区综合| 天美传媒精品一区二区| videossex国产| 91精品国产九色| 联通29元200g的流量卡| 国产老妇女一区| 22中文网久久字幕| 免费高清在线观看视频在线观看| 亚洲激情五月婷婷啪啪| 国产免费一级a男人的天堂| 亚洲国产高清在线一区二区三| 日日啪夜夜撸| 久久久久久久久久黄片| 日韩精品有码人妻一区| 精华霜和精华液先用哪个| 热99在线观看视频| 免费av毛片视频| 亚洲伊人久久精品综合| 国产精品国产三级国产av玫瑰| 亚洲精品色激情综合| 最近视频中文字幕2019在线8| 91久久精品国产一区二区成人| 最近手机中文字幕大全| 国产精品嫩草影院av在线观看| 色视频www国产| 国产 一区 欧美 日韩| 日韩在线高清观看一区二区三区| 夫妻性生交免费视频一级片| 1000部很黄的大片| 又大又黄又爽视频免费| 日韩大片免费观看网站| 99久久中文字幕三级久久日本| 欧美高清性xxxxhd video| 婷婷色av中文字幕| 亚洲国产成人一精品久久久| 国产单亲对白刺激| 久久久久久久国产电影| 午夜免费观看性视频| 国产黄片美女视频| 成年版毛片免费区| 亚洲欧美一区二区三区黑人 | 一个人看视频在线观看www免费| 夜夜看夜夜爽夜夜摸| 精华霜和精华液先用哪个| 卡戴珊不雅视频在线播放| 亚洲图色成人| 国产女主播在线喷水免费视频网站 | 三级国产精品片| 尾随美女入室| 亚洲美女视频黄频| 久久久久网色| 国产午夜精品一二区理论片| 美女主播在线视频| 毛片女人毛片| 国产精品不卡视频一区二区| 91av网一区二区| av在线播放精品| 亚洲美女搞黄在线观看| 精品不卡国产一区二区三区| 国产av不卡久久| 乱系列少妇在线播放| 日韩一区二区视频免费看| 日韩一本色道免费dvd| 嫩草影院精品99| 国产单亲对白刺激| 国产有黄有色有爽视频| a级毛片免费高清观看在线播放| 国产精品一二三区在线看| 搞女人的毛片| 国产精品国产三级国产av玫瑰| 久久久久精品性色| 亚洲精品一二三| 少妇人妻一区二区三区视频| 国模一区二区三区四区视频| 免费av观看视频| 深夜a级毛片| 美女内射精品一级片tv| 赤兔流量卡办理| 街头女战士在线观看网站| 国产av国产精品国产| 又爽又黄a免费视频| 国产免费一级a男人的天堂| 狂野欧美激情性xxxx在线观看| 欧美丝袜亚洲另类| 人人妻人人澡人人爽人人夜夜 | 蜜桃亚洲精品一区二区三区| 肉色欧美久久久久久久蜜桃 | 国产精品一区www在线观看| 国产午夜精品一二区理论片| av国产免费在线观看| 18禁裸乳无遮挡免费网站照片| 成人综合一区亚洲| 97人妻精品一区二区三区麻豆| 午夜福利在线观看吧| 99热这里只有是精品50| 国产黄频视频在线观看| 一区二区三区免费毛片| 国产精品人妻久久久久久| 亚洲精品,欧美精品| 久久6这里有精品| 极品少妇高潮喷水抽搐| av网站免费在线观看视频 | 日韩视频在线欧美| 亚洲精品日韩av片在线观看| 午夜精品在线福利| 十八禁网站网址无遮挡 | 国产伦精品一区二区三区四那| 人人妻人人澡欧美一区二区| 亚洲综合精品二区| 亚洲欧美日韩东京热| 日本wwww免费看| 亚洲最大成人手机在线| 国产伦在线观看视频一区| 成人国产麻豆网| 久久久久网色| 波野结衣二区三区在线| 久久久久久国产a免费观看| 国产精品伦人一区二区| 永久网站在线| 男女边吃奶边做爰视频| 禁无遮挡网站| 久久久久久九九精品二区国产| 网址你懂的国产日韩在线| 国产午夜精品久久久久久一区二区三区| 国产黄色小视频在线观看| 最近2019中文字幕mv第一页| 亚洲av不卡在线观看| 又黄又爽又刺激的免费视频.| 国产白丝娇喘喷水9色精品| 亚州av有码| 狂野欧美白嫩少妇大欣赏| 国内精品一区二区在线观看| 亚洲精品456在线播放app| 18+在线观看网站| 黄片wwwwww| 毛片女人毛片| 白带黄色成豆腐渣| 搡老乐熟女国产| 中文字幕制服av| 精品一区二区三区人妻视频| 亚洲国产精品成人综合色| 熟妇人妻不卡中文字幕| 欧美xxⅹ黑人| 一二三四中文在线观看免费高清| 免费人成在线观看视频色| 黄片无遮挡物在线观看| 精品久久久精品久久久| 精品少妇黑人巨大在线播放| 色综合站精品国产| 欧美成人午夜免费资源| 2022亚洲国产成人精品| 久久久久九九精品影院| 国产探花极品一区二区| 国产av不卡久久| 男人狂女人下面高潮的视频| 精品人妻偷拍中文字幕| 亚洲精品国产av成人精品| 免费av观看视频| 免费av毛片视频| 日韩一区二区三区影片| 欧美变态另类bdsm刘玥| 国产黄频视频在线观看| 久久久久九九精品影院| 乱码一卡2卡4卡精品| 插逼视频在线观看| 91久久精品国产一区二区成人| 欧美潮喷喷水| 亚洲精品乱久久久久久| 国产久久久一区二区三区| 成人毛片a级毛片在线播放| 少妇裸体淫交视频免费看高清| 中文字幕人妻熟人妻熟丝袜美| 神马国产精品三级电影在线观看| 成年人午夜在线观看视频 | 日韩伦理黄色片| 久99久视频精品免费| 黄色一级大片看看| 久久久久久久午夜电影| 天堂网av新在线| 91av网一区二区| av女优亚洲男人天堂| 岛国毛片在线播放| 在线观看美女被高潮喷水网站| videos熟女内射| 久久99精品国语久久久| 国产黄色视频一区二区在线观看| 亚洲欧美一区二区三区黑人 | 亚洲丝袜综合中文字幕| 夜夜看夜夜爽夜夜摸| 在线免费观看的www视频| 丰满少妇做爰视频| 免费少妇av软件| 国产高潮美女av| 少妇裸体淫交视频免费看高清| 麻豆av噜噜一区二区三区| 国产成人freesex在线| 久久精品夜夜夜夜夜久久蜜豆| 日韩三级伦理在线观看| 国产av不卡久久| av卡一久久| 亚洲国产成人一精品久久久| 亚洲成人精品中文字幕电影| 久久久色成人| 在线天堂最新版资源| 一夜夜www| 秋霞伦理黄片| 亚洲精品色激情综合| 国产精品蜜桃在线观看| 只有这里有精品99| 最近2019中文字幕mv第一页| 国产女主播在线喷水免费视频网站 | 免费黄网站久久成人精品| a级一级毛片免费在线观看| 九草在线视频观看| 日本-黄色视频高清免费观看| 精华霜和精华液先用哪个| 日韩亚洲欧美综合| 最近中文字幕2019免费版| 听说在线观看完整版免费高清| 免费少妇av软件| 热99在线观看视频| 如何舔出高潮| 美女大奶头视频| 午夜激情欧美在线| 欧美精品一区二区大全| 日韩欧美精品免费久久| 久久久久久久久久成人| 日韩强制内射视频| 欧美97在线视频| 精品一区二区免费观看| 别揉我奶头 嗯啊视频| 免费看a级黄色片| 精品欧美国产一区二区三| 三级经典国产精品| 久久97久久精品| 国产午夜精品一二区理论片| 国国产精品蜜臀av免费| 99热这里只有是精品50| 久久久成人免费电影| 免费看日本二区| 中文字幕av成人在线电影| 最后的刺客免费高清国语| 九草在线视频观看| 国产av国产精品国产| 中国美白少妇内射xxxbb| 精品久久国产蜜桃| 国产淫语在线视频| 亚洲国产欧美在线一区| 精品久久久噜噜| 久久久久久伊人网av| 精品99又大又爽又粗少妇毛片| 亚洲精品久久久久久婷婷小说| 亚洲国产精品成人久久小说| 精品一区二区三区人妻视频| 好男人在线观看高清免费视频| 欧美日韩综合久久久久久| 成人午夜高清在线视频| 少妇熟女aⅴ在线视频| 欧美一区二区亚洲| 国产伦理片在线播放av一区| 欧美性感艳星| 麻豆成人av视频| 亚洲精品国产成人久久av| 99热这里只有是精品50| 国产精品一区二区三区四区久久| 亚洲精品一区蜜桃| 日日撸夜夜添| 最近最新中文字幕大全电影3| 成人国产麻豆网| 欧美 日韩 精品 国产| 22中文网久久字幕| 狂野欧美白嫩少妇大欣赏| 两个人的视频大全免费| 亚洲综合精品二区| 欧美人与善性xxx| av又黄又爽大尺度在线免费看| 日韩一区二区三区影片| 少妇的逼水好多| 成人毛片a级毛片在线播放| 七月丁香在线播放| 久久精品国产亚洲网站| 久久99精品国语久久久| 亚洲一区高清亚洲精品| 中文欧美无线码| 99热全是精品| 亚洲精品视频女| 精品人妻熟女av久视频| 国内少妇人妻偷人精品xxx网站| 一本一本综合久久| 国产女主播在线喷水免费视频网站 | 91狼人影院| 激情 狠狠 欧美| 观看免费一级毛片| 国产 亚洲一区二区三区 | 亚洲精品456在线播放app| 国产精品福利在线免费观看| 麻豆乱淫一区二区| 日韩一本色道免费dvd| 久久久久精品性色| 日韩人妻高清精品专区| 国产成人aa在线观看| 国产精品综合久久久久久久免费| 狂野欧美白嫩少妇大欣赏| av网站免费在线观看视频 | 精品国产露脸久久av麻豆 | 大香蕉久久网| 91久久精品国产一区二区成人| 成人高潮视频无遮挡免费网站| 在线观看美女被高潮喷水网站| 人妻一区二区av| 亚洲最大成人av| 欧美高清成人免费视频www| 激情五月婷婷亚洲| 91精品一卡2卡3卡4卡| 久久久精品欧美日韩精品| 亚洲精品一二三| 乱人视频在线观看| 不卡视频在线观看欧美| 欧美zozozo另类| 色综合色国产| 精品一区在线观看国产| 久久久久久久大尺度免费视频| 久久久久免费精品人妻一区二区| 人人妻人人澡欧美一区二区| 久久久久久国产a免费观看| 亚洲一区高清亚洲精品| 亚洲欧美日韩无卡精品| 99热这里只有精品一区| 免费播放大片免费观看视频在线观看| 日日啪夜夜爽| 草草在线视频免费看| 三级国产精品片| 国产精品人妻久久久久久| 日韩伦理黄色片| 插阴视频在线观看视频| 精品少妇黑人巨大在线播放| 久久人人爽人人爽人人片va| 能在线免费看毛片的网站| 中文字幕av在线有码专区| 一级毛片电影观看| 小蜜桃在线观看免费完整版高清| 偷拍熟女少妇极品色| 久久精品国产亚洲av涩爱| 日韩成人av中文字幕在线观看| 99re6热这里在线精品视频| 久久99热这里只频精品6学生| 不卡视频在线观看欧美| 亚洲婷婷狠狠爱综合网| 永久网站在线| 51国产日韩欧美| 亚洲精品亚洲一区二区| 亚洲精品456在线播放app| 国产一区二区在线观看日韩| 亚洲av在线观看美女高潮| 色综合亚洲欧美另类图片| 国产综合懂色| 日本猛色少妇xxxxx猛交久久| 小蜜桃在线观看免费完整版高清| 观看美女的网站| 搞女人的毛片| 好男人视频免费观看在线| 高清午夜精品一区二区三区| 乱系列少妇在线播放| 日日啪夜夜撸| 亚洲av电影不卡..在线观看| 精品一区二区免费观看| 青春草视频在线免费观看| 丰满乱子伦码专区| 十八禁网站网址无遮挡 | 午夜精品一区二区三区免费看| 亚洲欧美精品专区久久| 少妇人妻精品综合一区二区| 国产精品一区二区性色av| 毛片女人毛片| 大陆偷拍与自拍| 色综合站精品国产| 欧美成人午夜免费资源| 永久免费av网站大全| 搡老妇女老女人老熟妇| 国产成人freesex在线| av卡一久久| 亚洲国产高清在线一区二区三| 麻豆成人午夜福利视频| av播播在线观看一区| 亚洲av电影不卡..在线观看| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 黄色欧美视频在线观看| 舔av片在线| 搞女人的毛片| 日韩欧美精品免费久久| 在线观看av片永久免费下载| 女人被狂操c到高潮| eeuss影院久久| 日韩欧美国产在线观看| 一级a做视频免费观看| 看黄色毛片网站| 一个人免费在线观看电影| 成人亚洲精品一区在线观看 | 国产精品人妻久久久影院| 天堂av国产一区二区熟女人妻| 中国国产av一级| 亚洲最大成人中文| 高清欧美精品videossex| 久久热精品热| 久热久热在线精品观看| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 日韩成人av中文字幕在线观看| 日韩成人伦理影院| 久久6这里有精品| 亚洲成人av在线免费| 国产精品久久久久久精品电影小说 | 免费看不卡的av| 两个人视频免费观看高清| 国产熟女欧美一区二区| 午夜激情福利司机影院| 又大又黄又爽视频免费| 欧美97在线视频| 欧美性感艳星| 精品不卡国产一区二区三区| 最近的中文字幕免费完整| 亚洲成人中文字幕在线播放| 日韩欧美国产在线观看| 亚洲精品国产成人久久av| 人妻制服诱惑在线中文字幕| 大香蕉97超碰在线| 人人妻人人澡欧美一区二区| 日日啪夜夜爽| 男女国产视频网站| 大香蕉久久网| 国产淫片久久久久久久久| 街头女战士在线观看网站| av线在线观看网站| 久久精品综合一区二区三区| 色综合色国产| 亚洲欧美中文字幕日韩二区| 精品久久久久久久久亚洲| 十八禁国产超污无遮挡网站| 欧美性感艳星| 国产av码专区亚洲av| 午夜激情福利司机影院| 搡女人真爽免费视频火全软件| 又黄又爽又刺激的免费视频.| 狂野欧美激情性xxxx在线观看| 99久久九九国产精品国产免费| 日本欧美国产在线视频| 亚洲真实伦在线观看| 久久精品国产亚洲av天美| 久久人人爽人人爽人人片va| 伊人久久精品亚洲午夜| 春色校园在线视频观看| 亚洲乱码一区二区免费版| 直男gayav资源| 国产av不卡久久| 伊人久久精品亚洲午夜| 在现免费观看毛片| 久久国产乱子免费精品| 久久久a久久爽久久v久久| 男女国产视频网站| 免费av不卡在线播放| 国产精品一区www在线观看| 亚洲精品成人久久久久久| 亚洲av成人精品一区久久| av在线天堂中文字幕| 亚洲经典国产精华液单| 97精品久久久久久久久久精品| 久久精品夜夜夜夜夜久久蜜豆| 久久精品熟女亚洲av麻豆精品 | 亚洲欧美成人精品一区二区| 亚洲精品影视一区二区三区av| 国产免费一级a男人的天堂| 干丝袜人妻中文字幕| 亚洲精品乱久久久久久| 欧美激情国产日韩精品一区| 亚洲精品国产av成人精品| 免费高清在线观看视频在线观看| 国产在视频线在精品| 搡老乐熟女国产| 在线a可以看的网站| 菩萨蛮人人尽说江南好唐韦庄| 小蜜桃在线观看免费完整版高清| 好男人视频免费观看在线| 亚洲精品亚洲一区二区| 日日啪夜夜爽| 久久久精品欧美日韩精品| 欧美区成人在线视频| 少妇人妻精品综合一区二区| 国产成人91sexporn| 在线播放无遮挡| 最后的刺客免费高清国语| 蜜臀久久99精品久久宅男| 久久精品国产亚洲av天美| 激情五月婷婷亚洲| 国产老妇女一区| 国产视频内射| 七月丁香在线播放| 欧美+日韩+精品| 午夜精品在线福利| 国产一区二区在线观看日韩| 午夜免费观看性视频| 性插视频无遮挡在线免费观看| 日韩av在线免费看完整版不卡| 亚洲精品一区蜜桃| 一级二级三级毛片免费看| 日本-黄色视频高清免费观看| 国产一级毛片在线| 九色成人免费人妻av| 久久久久久久久久久免费av| 少妇人妻精品综合一区二区| 国产成人免费观看mmmm| 日日摸夜夜添夜夜添av毛片| 国产在视频线精品| 欧美xxⅹ黑人| 久久久久精品性色| av天堂中文字幕网| 日韩av在线免费看完整版不卡| 午夜激情欧美在线| 国产精品福利在线免费观看| 女人被狂操c到高潮| av国产免费在线观看| 欧美丝袜亚洲另类| 免费看a级黄色片| 婷婷色av中文字幕| av免费观看日本| 少妇人妻精品综合一区二区| 免费av不卡在线播放| 亚洲欧美清纯卡通| 亚洲色图av天堂| 亚洲av一区综合| 高清视频免费观看一区二区 | 欧美一级a爱片免费观看看| 有码 亚洲区| 亚洲av中文字字幕乱码综合| 青春草亚洲视频在线观看| 熟妇人妻久久中文字幕3abv| 亚洲婷婷狠狠爱综合网| 人妻夜夜爽99麻豆av| 三级毛片av免费| 精华霜和精华液先用哪个| 欧美高清性xxxxhd video| 亚洲18禁久久av| 亚洲人成网站在线观看播放| 日日干狠狠操夜夜爽| 免费观看在线日韩| 非洲黑人性xxxx精品又粗又长| 亚洲精品成人久久久久久| 十八禁国产超污无遮挡网站| 精品一区在线观看国产| 免费大片黄手机在线观看| 国产免费视频播放在线视频 | 在线 av 中文字幕| 久久99蜜桃精品久久| 晚上一个人看的免费电影| 久久99热这里只有精品18| 极品少妇高潮喷水抽搐| 一级毛片电影观看| 欧美三级亚洲精品| 99热这里只有精品一区| 99九九线精品视频在线观看视频| 午夜福利网站1000一区二区三区| 亚洲美女搞黄在线观看| 少妇裸体淫交视频免费看高清| 国产永久视频网站| 又黄又爽又刺激的免费视频.|